Principal Financial Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1K | Buy |
|
|||||
|
2025
Q1 | $21.8K | Buy |
|
|||||
|
2024
Q4 | $27.9K | Sell |
|
|||||
|
2024
Q3 | $32.6K | Sell |
|
|||||
|
2024
Q2 | $50.4K | Sell |
|
|||||
|
2024
Q1 | $226K | Sell |
|
|||||
|
2023
Q4 | $603K | Sell |
|
|||||
|
2023
Q3 | $536K | Buy |
|
|||||
|
2023
Q2 | $794K | Sell |
|
|||||
|
2023
Q1 | $703K | Buy |
|
|||||
|
2022
Q4 | $398K | Sell |
|
|||||
|
2022
Q3 | $284K | Buy |
|
|||||
|
2022
Q2 | $162K | Sell |
|
|||||
|
2022
Q1 | $431K | Sell |
|
|||||
|
2021
Q4 | $986K | Sell |
|
|||||
|
2021
Q3 | $1.7M | Sell |
|
|||||
|
2021
Q2 | $2.5M | Sell |
|
|||||
|
2021
Q1 | $2.54M | Sell |
|
|||||
|
2020
Q4 | $2M | Buy |
|
|||||
|
2020
Q3 | $552K | Buy |
|
|||||
|
2020
Q2 | $193K | Buy |
|
|||||
|
2020
Q1 | $61K | Buy |
|
|||||
|
2019
Q4 | $98K | Sell |
|
|||||
|
2019
Q3 | $115K | Buy |
|
|||||
|
2019
Q2 | $110K | Sell |
|
|||||
|
2019
Q1 | $139K | Sell |
|
|||||
|
2018
Q4 | $265K | Sell |
|
|||||
|
2018
Q3 | $240K | Buy |
|
|||||
|
2018
Q2 | $138K | Buy |
|
|||||
|
2018
Q1 | $72K | Sell |
|
|||||
|
2017
Q4 | $95K | Buy |
|
|||||
|
2017
Q3 | $73K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $78K | Sell |
|
|||||
|
2016
Q4 | $59K | Sell |
|
|||||
|
2016
Q3 | $227K | Buy |
|
|||||
|
2016
Q2 | $101K | Buy |
|
|||||
|
2016
Q1 | $104K | Buy |
|
|||||
|
2015
Q4 | $135K | Hold |
|
|||||
|
2015
Q3 | $38K | Sell |
|
|||||
|
2015
Q2 | $97K | Sell |
|
|||||
|
2015
Q1 | $100K | Buy |
|
|||||
|
2014
Q4 | $125K | Sell |
|
|||||
|
2014
Q3 | $92K | Hold |
|
|||||
|
2014
Q2 | $116K | Sell |
|
|||||
|
2014
Q1 | $108K | Sell |
|
|||||
|
2013
Q4 | $108K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $52K | Buy |
|